[1] Saad WE.Endovascular management of gastric varices. Clin Liver Dis,2014,18(4):829-851. [2] Ríos E,Serón P,Lanas F,et al.Evaluation of the quality of clinical practice guidelines for the management of esophageal or gastric variceal bleeding. Eur J Gastroenterol Hepatol,2014,26(4):422-31. [3] Gracia-Sancho J,Maeso-Díaz R,Bosch J.Pathophysiology and a rational basis of therapy. Dig Dis,2015,33(4):508-514. [4] Gralnek IM,Dumonceau JM,Kuipers EJ,et al.Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage:European Society of Gastrointestinal Endoscopy(ESGE) Guideline. Endoscopy,2015,47(10):a1-46. [5] Laine L,Jensen DM. Management of patients with ulcer bleeding. Am J Gastroenterol,2012,107(3):345-360;quiz 361. [6] Seo YS,Park SY,Kim MY,et al.Lack of difference among terlipressin,somatostatin,and octreotide in the control of acute gastroesophageal variceal hemorrhage. Hepatology,2014,60(3):954-963. [7] Satapathy SK,Sanyal AJ.Nonendoscopic management strategies for acute esophagogastric variceal bleeding. Gastroenterol Clin North Am,2014,43(4):819-833. [8] García-Pagán JC,Reverter E,Abraldes JG,et al.Acute variceal bleeding. Semin Respir Crit Care Med,2012,33(1):46-54. [9] Bhutta AQ,Garcia-Tsao G.The role of medical therapy for variceal bleeding. Gastrointest Endosc Clin N Am,2015,25(3):479-490. [10] Kumar A,Jha SK,Mittal VV,et al.Addition of somatostatin after successful endoscopic variceal ligation does not prevent early rebleeding in comparison to placebo:A double blind randomized controlled trial. J Clin Exp Hepatol,2015,5(3):204-212. [11] Zhang C,Xu JM,Kong DR,et al.Immediate effects of different schedules of somatostatin on portal pressure in patients with liver cirrhosis. J Clin Pharm Ther,2013,38(3):206-211. [12] Gupta V,Rawat R,Shalimar,et al. Carvedilol versus propranolol effect on hepatic venous pressure gradient at 1 month in patients with index variceal bleed: RCT. Hepatol Int,2017,11(2):181-187. [13] Wang C,Han J,Xiao L,et al.Efficacy of vasopressin/terlipressin and somatostatin/octreotide for the prevention of early variceal rebleeding after the initial control of bleeding:a systematic review and meta-analysis. Hepatol Int,2015,9(1):120-129. [14] Alempijevi T,Balovi A,Pavlovi-Markovi A,et al.Efficacy of long-acting somatostatin analogs in recurrent variceal bleeding in a patient with pre-hepatic portal vein thrombosis. Vojnosanit Pregl,2015,72(3):283-286. [15] Gracia-Sancho J,Maeso-Díaz R,Fernández-Iglesias A,et al.New cellular and molecular targets for the treatment of portal hypertension. Hepatol Int,2015,9(2):183-191. [16] Imamura H,Irisawa A,Shibukawa G,et al.Echo-endoscopic analysis of variceal hemodynamics in patient with isolated gastric varices. Endosc Ultrasound,2014,3(4):238-244. [17] Alicioglu B,Sarikaya A,Bulakbasi N.Interrelationship between liver hemodynamics and tumor metabolism in liver metastases: diagnostic value of Doppler perfusion index revisited. Prague Med Rep,2013,114(2):103-112. [18] 杨卫生,郭武华. 肝硬化门静脉高压症患者肝脏血流动力学指标与门静脉压力的相关性研究. 中国全科医学,2016,19(23):2784-2788. [19] Tang YH,Luo Y,Wen TF,et al.Portal hemodynamics before and after liver resection and its correlation with post-hepatectomy liver failure in patients with Child-Pugh class A:analysis of 151 consecutive cases. Hepatogastroenterology,2014,61(129):42-47. |